Close Menu

HIV

The HIV center, located in a New York City suburb, will allow Profectus in December to accommodate more than 20 new researchers it plans to hire over the next two years, in addition to the 13 now based in temporary space.

The agreement comes approximately three months after ABL and Stanford reached their own settlement in the suit, in which ABL accused the university and professor of breaching a patent immunity contract regarding Stanford's HIV Drug Resistance Database.

LabCorp's $107 million offer to acquire Monogram gives it access to molecular diagnostics and pharmacogenomic tests that are clinically validated and are free of regulatory challenges. Although Monogram wasn't looking to be acquired, the deal would allow broader marketing of its tests by using LabCorp's national infrastructure.

The UCSF Viral Diagnostics and Discovery Center will use sequencing, microarrays, and other genomic technologies to characterize pathogens linked to acute and chronic human illnesses.

The study, begun last year, will take longer than the June 2009 timeframe projected late last year. It calls for the NIH to analyze the ability of the Biosafety Level 4 lab to contain 13 toxins to be studied there, and ensure it can run safely.

MTTC links up with iBridge Network; ViroStatics licenses compound library from University of Siena; Ben-Gurion University inks research pact with Bayer CropScience, and more …

The first in a series of programs will support studies of HIV-1 persistence, including host and pathogen genetics.

Obama Ends hESC Research Restrictions, Connecticut Innovations, Helix Therapeutics, Canadian Forest Nanoproducts Network, Québec Consortium for Drug Discovery, Wisconsin Opportunity Grants, Wisconsin Emerging Industries Skills Partnership, Qatar Science & Technology Park

Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.